Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
661 to 680 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrated analysis of cervical squamous cell carcinoma cohorts from three continents reveals conserved subtypes of prognostic significance. | Nat Commun | 2022 | 36207323 | PubTator, text mining | PubMed |
| LMO3 downregulation in PCa: A prospective biomarker associated with immune infiltration. | Front Genet | 2022 | 36199576 | PubTator, text mining | PubMed |
| Capicua suppresses YAP1 to limit tumorigenesis and maintain drug sensitivity in human cancer. | Cell Rep | 2022 | 36198276 | PubTator, text mining | PubMed |
| lncRNA PVT1: a novel oncogene in multiple cancers. | Cell Mol Biol Lett | 2022 | 36195846 | PubTator, text mining | PubMed |
| S100P promotes trophoblast syncytialization during early placenta development by regulating YAP1. | Front Endocrinol (Lausanne) | 2022 | 36187124 | PubTator, text mining | PubMed |
| Long non-coding RNAs affecting cell metabolism in cancer. | Biol Direct | 2022 | 36182907 | PubTator, text mining | PubMed |
| BRAF Inhibitor Resistance in Melanoma: Mechanisms and Alternative Therapeutic Strategies. | Curr Treat Options Oncol | 2022 | 36181568 | PubTator, text mining | PubMed |
| YAP/Smad3 promotes pathological extracellular matrix microenviroment-induced bladder smooth muscle proliferation in bladder fibrosis progression. | MedComm (2020) | 2022 | 36176734 | PubTator, text mining | PubMed |
| A nuclear cAMP microdomain suppresses tumor growth by Hippo pathway inactivation. | Cell Rep | 2022 | 36170819 | PubTator, text mining | PubMed |
| Reciprocal positive regulation between BRD4 and YAP in GNAQ-mutant uveal melanoma cells confers sensitivity to BET inhibitors. | Pharmacol Res | 2022 | 36162600 | PubTator, text mining | PubMed |
| Regulation of pancreatic cancer metastasis through the Gli2-YAP1 axis via regulation of anoikis. | Genes Dis | 2022 | 36157479 | PubTator, text mining | PubMed |
| Perfluorooctanoic acid (PFOA) promotes follicular growth and alters expression of genes that regulate the cell cycle and the Hippo pathway in cultured neonatal mouse ovaries. | Toxicol Appl Pharmacol | 2022 | 36152675 | PubTator, text mining | PubMed |
| Application of miRNA Biomarkers in Predicting Overall Survival Outcomes for Lung Adenocarcinoma. | Biomed Res Int | 2022 | 36147635 | PubTator, text mining | PubMed |
| Crosstalk between Hypoxia and Extracellular Matrix in the Tumor Microenvironment in Breast Cancer. | Genes (Basel) | 2022 | 36140753 | PubTator, text mining | PubMed |
| Application of Micro-Western Array for Identifying Different Serum Protein Expression Profile among Healthy Control, Alzheimer's Disease Patients and Patients' Adult Children. | Brain Sci | 2022 | 36138870 | PubTator, text mining | PubMed |
| Deciphering the endometrial immune landscape of RIF during the window of implantation from cellular senescence by integrated bioinformatics analysis and machine learning. | Front Immunol | 2022 | 36131919 | PubTator, text mining | PubMed |
| CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ. | J Exp Clin Cancer Res | 2022 | 36131287 | PubTator, text mining | PubMed |
| The high mobility group protein HMG20A cooperates with the histone reader PHF14 to modulate TGFβ and Hippo pathways. | Nucleic Acids Res | 2022 | 36124662 | PubTator, text mining | PubMed |
| CAF-derived exosomal WEE2-AS1 facilitates colorectal cancer progression via promoting degradation of MOB1A to inhibit the Hippo pathway. | Cell Death Dis | 2022 | 36123327 | PubTator, text mining | PubMed |
| Knockdown of NDUFC1 inhibits cell proliferation, migration, and invasion of hepatocellular carcinoma. | Front Oncol | 2022 | 36119539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=34